Trevi Therapeutics, Inc. - TRVI
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 07, 2026 | SCHEDULE 13D/A | — | 1.0% | — | View |
| May 06, 2026 | SCHEDULE 13G/A | FMR LLC | 6.3% | 8,038,061 | View |
| May 06, 2026 | SCHEDULE 13G/A | Abigail P. Johnson | 6.3% | 8,038,061 | View |
| Mar 27, 2026 | SCHEDULE 13G/A | The Vanguard Group | 0.0% | 0 | View |
| Feb 13, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Feb 13, 2026 | SCHEDULE 13G/A | Rubric Capital Management LP | 2.94% | 3,766,749 | View |
| Feb 13, 2026 | SCHEDULE 13G/A | David Rosen | 2.94% | 3,766,749 | View |
| Feb 05, 2026 | SCHEDULE 13G | FMR LLC | 5.1% | 6,500,009 | View |
| Feb 05, 2026 | SCHEDULE 13G | Abigail P. Johnson | 5.1% | 6,500,009 | View |
| Jan 30, 2026 | SCHEDULE 13G | The Vanguard Group | 5.01% | 6,434,655 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.